Use of nonprohibited hallucinogenic plants: Increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage)

Pharmacopsychiatry

Volumn 38, Issue 1, 2005, Pages 1-5

  Bucheler R ^a,b   Gleiter, Christoph H ^a   Schwoerer, P ^b   Gaertner, I ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b MDK Baden Wurttemberg H R R H   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DITERPENE; DYNORPHIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; LYSERGIDE; MESCALINE; NALOXONE; NALTREXONE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; PLANT EXTRACT; PSILOCYBINE; PSYCHEDELIC AGENT; SALVIA DIVINORUM EXTRACT; SALVINORIN A; UNCLASSIFIED DRUG;

ANALGESIA; DEPERSONALIZATION; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG METABOLISM; DRUG SCREENING; DYSPHORIA; EUROPE; HALLUCINATION; HEART ARRHYTHMIA; HUMAN; INGESTION; INTERNET; LEGAL ASPECT; MEXICO; NONHUMAN; PHARMACODYNAMICS; PLANT; PRIORITY JOURNAL; REVIEW; SALVIA; SALVIA DIVINORUM; SEDATION; SIDE EFFECT; SMOKING;

ADULT; DITERPENES; HALLUCINOGENS; HUMANS; LEGISLATION, DRUG; MALE; MEXICO; PSYCHOTROPIC DRUGS; PUBLIC HEALTH; SALVIA;

EID: 14044268059     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837763     Document Type: Review

References (48)

1. All about salvia divinorum 2004, http://www.salvia-divinorum.nl/ GUIDELINES.HTM (18.01.2005)
2. allsalvia.co.uk 2004. http://www.allsalvia.co.uk (01.03.2004).
3. Bundeskriminalamt Wiesbaden. Rauschgiftjahresbericht 2002. http:// www.bka.de/lageberichte/rg/2002/b_aktuelle_tendenzen.pdf (27.02.2004).
4. Butelman ER, Harris TJ, Kreek MJ. The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys. Psychopharmacology 2004; 172: 220-224
5. Center for Cognitive Liberty & Ethics 2003. http:// wwwcognitivelibertyorg/news/salvia_australiahtm (01.03.2004).
6. Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ et al. Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious (kappa)-opioid receptor agonist: Structural and functional considerations. J Pharmacol Exp Ther 2004; 308: 1197-1203
7. Chung T, Colby SM, O'Leary TA, Barnett NP, Monti PM. Screening for cannabis use disorders in an adolescent emergency department sample. Drug Alcohol Depend 2003; 70: 177-186
8. Coles JA Jr, Sigg DC, Iaizzo PA. Role of kappa-opioid receptor activation in pharmacological preconditioning of swine. Am J Physiol Heart Circ Physiol 2003; 284: H2091-2099
9. Degenhardt L, Hall W, Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 2003; 71: 37-48
10. Dinkel M, Bedner M. Biological addictive drugs - A new trend. Notarzt, 2001: 105-107, DOI: 10.1055/s-2001-14123
11. Dittrich A. The standardized psychometric assessments of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry 1998; 31 (Suppl 2): 80-84
12. Eisenach JC, Carpenter R, Curry R. Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis. Pain 2003; 101: 89-95
13. Epling C, Játiva-M CD. A new species of Salvia from Mexico. Botanical Museum Leaflets Harvard University, 1962; 20: 75-84
14. Erowid.org 2004. http://www.erowid.org/plants/salvia/salvia_law.shtml (01.03.2004).
15. Freye E. Rezeptorinteraktionen von Agonisten, Antagonisten und partiellen Agonisten. In Freye E, editor. Opioide in der Medizin Berlin: Springer Verlag, 2001; 4th edition: p. 51-62
16. GetSalvia (2003) http://www.getsalvia.com/pages/feedbacks.phtml (27.02.2004).
17. Giroud C, Felber F, Augsburger M, Horisberger B, Rivier L, Mangin P. Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland. Forensic Sci Int 2000; 112: 143-150
18. Gopel C, Laufer C, Marcus A. Three cases of angel's trumpet tea-induced psychosis in adolescent substance abusers. Nord J Psychiatry 2002; 56: 49-52
19. Gruber JW, Siebert DJ, Der Marderosian AH, Hock RS. High performance liquid chromatographic quantification of Salvinorin A from tissues of Salvia divinorum Epling & Játiva-M. Phytochem Anal 1999; 10: 22-25
20. Hanes KR. Antidepressant Effects of the Herb Salvia Divinorum: A Case Report. J Clin Psychopharmacol 2001; 21: 634-635
21. Hansen G, Jensen SB, Chandresh L, Hilden T. The psychotropic effect of ketamine. J Psychoactive Drug 1988; 20: 419-425
22. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991; 148: 1301-1308
23. Lesscher HM, Bailey A, Burbach JPH, van Ree JM, Kitchen I, Gerrits MAFM. Receptor-selective changes in mu- delta- and kappa-opioid receptors after chronic naltrexone treatment in mice. Eur J Neurosci 2003; 17: 1006-1012
24. Lewanowitsch T, Irvine RJ. Naloxone and its quaternary derivative naloxone methiodide have differing affinities for mu, delta and kappa opioid receptors in mouse brain homogenates. Brain Res 2003; 964: 302-305
25. Lotus paradise 2004. http://www.salvia-divinorum.com (01.03.2004).
26. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC et al. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 2003; 305: 323-330
27. Munro TA, Rizzacasa MA, Salvinorins D-F new neoclerdane diterpenoids from Salvia divinorum and an improved method for the isolation of Salvinorin A. J Nat Prod 2003; 66: 703-705
28. Niess C, Schnabel A, Kauert G. Angel trumpet: a poisonous garden plant as a new addictive drug? Dtsch Med Wochenschr 1999; 124: 1444-1447
29. Ortega A, Blount JF, Machand PS. Salvinorin a new trans-neoclerodane diterpene from Salvia divinorum (Labiatae). J Chem Soc Perkin Trans 1982; 1: 2505-2508
30. Pfeiffer A, Brantl V, Herz A, Emrich HM. Psychotomimesis mediated by kappa opiate receptors. Science 1986; 233: 774-776
31. Pflanzenpfade Online Shop 2004. http://www.pflanzenpfade.de/start2. html (01.03.2004).
32. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S et al. Salvinorin A: A potent naturally occurring nonnitrogenous opioid selective agonist. PNAS 2002; 99: 11934-11939
33. Salvia Divinorum Alliance. (2004) http://groups.yahoo.com/group/ SalviaD_Alliance/message/11626 (27.02.2004).
34. Schabner D. A new LSD? Mexican herb for sale online comes with divine claims warnings. ABCNews com 2002 April 1 http://www.maps. org/media/abcsalvia. html (01.03.2004).
35. Schizo 2004. http://www.goatrance.de/goacidia/salvia/de-salvia-faq. html (01.03.2004).
36. Sheffler DJ, Roth BL. Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor. Trends Pharmacol Sci 2003; 24: 107-109
37. Siebert DJ. Salvia divinorum and Salvinorin A: new pharmacologic findings. J Ethnopharmacol 1994; 43: 53-56
38. Siebert DJ. Salvinorin A: Notes of Caution. The Entheogen Review 1994; 3: 19
39. Sinchaisuk S, Ho IK, Rockhold RW. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis. Pharmacol Biochem Behav 2002; 74: 241-252
40. Soutar I. Skapastora - Leaves of the Shepherdness. Conference at Breitenbush Hot Springs Dec 7-10, 2000. MAPS 2001; 11: 32-37
41. Sun XG, Dalman FC. Evidence for multiple mechanisms of kappa opioid tolerance in mesencephalic cultures. Brain Res 2003; 973: 122-130
42. The Salvia divinorum Research and Information Center 2004. http:// www.sagewisdom.org (27.02.2004).
43. Valdés 3rd LJ. Saliva divinorum and the unique diterpene hallucinogen Salvinorin (Divinorin A). J Psychoactive Drugs 1994; 26: 277-283
44. Valdés 3rd LJ, Chang HM, Visger DC. Salvinorin C, a new neoclerodecane diterpene from a bioactive fraction of the hallucinogenic mexican mint Salvia divinorum. Org Lett 2001; 3: 3935-3937
45. Valdés 3rd LJ, Diaz JL, Paul AG. Ethnopharmacology of Ska Maria Pastora (Salvia divinorum Epling and Játiva-M). Journal of Ethnopharmacology 1983; 7: 287-312
46. Wadenberg ML. A review of the properties of Spiradoline: A potent and selective kappa-opioid receptor agonist. CNS Drug Rev 2003; 9: 187-198
47. Wong TM, Wu S. Role of kappa opioid receptor in cardioprotection of preconditioning: implications in cardiac surgery. J Card Surg 2002; 17: 462-464
48. Wright RC, Ingenito AJ. Blockade of dorsal hippocampal kappa-opioid receptors increases blood pressure in normotensive and isolation-induced hypertensive rats. Neuropeptides 2003; 37: 127-132